Effect of β2glycoprotein I and human monoclonal anticardiolipin antibody on the protein S/C4b-binding protein system

Lupus

Volumn 6, Issue 4, 1997, Pages 358-364

  Atsumi, T ^a   Khamashta, M A ^a   Ames, P R J ^a   Ichikawa, K ^b   Koike, T ^b   Hughes, G R V ^a  

^a ST THOMAS HOSPITAL   (United Kingdom)

^b HOKKAIDO UNIVERSITY   (Japan)

Author keywords

Antiphosolipid syndrome; Antiphospholipid antibody; Coagulation; Thrombosis

Indexed keywords

BETA2 GLYCOPROTEIN 1; BINDING PROTEIN; CALCIUM ION; CARDIOLIPIN ANTIBODY; COMPLEMENT COMPONENT C4B BINDING PROTEIN; PROTEIN S; UNCLASSIFIED DRUG;

ANTIPHOSPHOLIPID SYNDROME; ARTICLE; PRIORITY JOURNAL; PROTEIN BINDING;

EID: 0030984801     PISSN: 09612033     EISSN: None     Source Type: Journal    
DOI: 10.1177/096120339700600403     Document Type: Article

References (42)

1. Koike T et al. Antiphospholipid antibodies and biological false positive serological test for syphilis in patients with systemic lupus erythematosus. Clin Exp Immunol 1984; 56: 193-199.
2. Harris EN. Antiphospholipid antibodies. Br J Haematol 1990; 74: 1-9.
3. Harris EN et al. Anti-cardiolipin antibodies: Detection by radioimmunoassay and association with thrombosis in systemic lupus erythematosus. Lancet 1983; ii: 1211-1214.
4. Harris EN et al. Thrombosis, recurrent fetal loss, and thrombocytopenia. Predictive value of the anticardiolipin antibody test Arch Intern Med 1986; 146: 2153-2156.
5. Roubey RAS. Autoantibodies to phospholipid-binding plasma proteins: a new view of lupus anticoagulants and other "antiphospholipid" antibodies. Blood 1994; 84: 2854-2867.
6. Galli M et al. Anticardiolipin antibodies (ACA) directed not to cardiolipin but to a plasma protein cofactor. Lancet 1990; 335: 952-953.
7. Matsuura E et al. Anticardiolipin cofactor(s) and differential diagnosis of autoimmune disease. Lancet 1990; 336: 177-178.
8. McNeil HP, Simpson RJ, Chesterman CN, Krilis SA. Anti-phospholipid antibodies are directed against a complex antigen that induces a lipid-binding inhibitor of coagulation: β2glycoprotein I (apolipoprotein H). Proc Natl Acad Sci USA 1990; 87: 4120-4124.
9. Kato H, Enjyoji K. Amino acid sequence and location of the disulfide bonds in bovine β2glycoprotein I: The presence of five Sushi domains. Biochemistry 1991; 30: 11687-11694.
10. Ichinose A, Bottenus RE, Davie EW. Structure of transglutaminase. J Biol Chem 1990; 265: 13411-13414.
11. Matsuura E et al Molecular definition of human β2glycoprotein I (β2GPI) by cDNA cloning and inter species differences of β-2GPI in alternation anticardiolipin binding. Int Immunol 1991; 3: 1217-1221.
12. Matsuura E et al. Anticardiolipin antibodies recognize β2glycoprotein I structure altered by interacting with an oxygen modified solid phase surface. J Exp Med 1994; 179: 457-462.
13. Nimpf J, Wurm H, Kostner M. Interaction of β2glycoprotein I with human blood platelets: Influences upon the ADP induced aggregation. Thromb Haemostas 1985; 54: 397-401.
14. Schousboe I, Rasmussen MS. Synchronized inhibition of the phospholipid mediated autoactivation of Factor XII in plasma by β2glycoprotein I and anti-β2-glycoprotein I. Thromb Haemostas 1995; 73: 798-804.
15. Schousboe I. β2glycoprotein I: Plasma inhibitor of contact activation of the intrinsic blood coagulation pathway. Blood 1985; 66: 1086-1091.
16. Shi W, Chong B, Hogg P, Chesterman C. Anticardiolipin antibodies block the inhibition by β2-glycoprotein I of the factor Xa generating activity of platelets. Thromb Haemostas 1993; 70: 342-345.
17. Bansci LF, van der Linden IK, Dertina RM. β2-glycoprotein I deficiency and the risk of thrombosis. Thromb Haemostas 1992; 67: 649-653.
18. Benedetti ED, Reber G, Miescher PA. No increase of β2-glycoprotein I levels in patients with antiphospholipid antibodies. Thromb Haemost 1992; 68: 624.
19. Brighton TA et al. Beta2-glycoprotein I in thrombosis: evidence for a role as a natural anticoagulant. Br J Haematol 1996; 93: 185-194.
20. Esmon CT. The roles of protein C and thrombomodulin in the regulation of blood coagulation. J Biol Chem 1989; 264: 4743-4746.
21. Keeling DM et al. Role of β2-glycoprotein I and anti-phospholipid antibodies in activation of protein C in vitro. J Clin Pathol 1993; 46: 908-911.
22. Bokarewa MI, Blomback M, Egberg N, Rosen S. A new variant of interaction between phospholipid antibodies and the protein C system. Blood Coag Fibrinol 1994; 5: 37-41.
23. Dahlbäck B. Protein S and C4b-binding protein: Components involved in the regulation of the protein C anticoagulant system. Thromb Haemost 1991; 66: 49-61.
24. Schmidel DK et al. Organization of the human protein S gene. Biochemistry 1990; 29: 7845-7852.
25. Comp PC, Doray D, Patton D, Esmon CT. An abnormal plasma distribution of protein S occurs in functional protein S deficiency. Blood 1986; 67: 504-508.
26. Mann KG et al. Surface-dependent reactions of the vitamin K-dependent enzyme complex. Blood 1990; 76: 1-16.
27. Parke A et al. The thrombotic diathesis associated with the presence of phospholipid antibodies may be due to low level of free protein S. Am J Med 1992; 93: 49-56.
28. Forastiero R, Kordich L, Basilotta E, Carreras L. Differences in protein S and C4b-binding protein levels in different groups of patients with antiphospholipid antibodies. Blood Coag Fibrinol 1994; 37: 1453-1461.
29. Ichikawa K et al. Reactivity of monoclonal anticardiolipin antibodies from patients with the antiphospholipid syndrome to β-2glycoprotein I. Arthritis Rheum 1994; 37: 1453-1461.
30. Matsuura E et al. Heterogeneity of anticardiolipin antibodies defined by the anticardiolipin cofactor. J Immunol 1992; 148: 3885-3891.
31. Saeki T et al. Evidence that C4b-binding protein is an acute phase protein. Biophys Res Commun 1989; 164: 1446-1451.
32. Frutos P, Alim R, Härdig, Dahlbäck B. Differential regulation of a and β chains of C4b-binding protein during acute-phase response resulting in stable plasma levels of free anticoagulant protein S. Blood 1994; 84: 815-822.
33. Barnum SR, Dahlbäck B. C4b-binding protein, a regulatory component of the classical pathway of complement, is an acute phase protein and is elevated in systemic lupus erythematosus. Complement Inflamm 1990; 7: 71-77.
34. Keeling DM et al. Total and free protein S in systemic lupus erythematosus. Thrombosis Research 1990; 60: 237-240.
35. Ruiz-Argüelles GJ et al. Natural anticoagulant in systemic lupus erythematosus. Deficiency of protein S bound to C4bp associated with recent history thrombosis, antiphospholipid antibodies, and the antiphospholipid syndrome. J Rheumatol 1991; 18: 552-558.
36. Hillarp A, Dahlbäck B. Cloning of cDNA coding for the β-chain of human complement C4b-binding protein gene: sequence homology with the α-chain. Proc Natl Acad Sci USA 1989; 87: 1183-1187.
37. Griffin JH, Gruber A, Fernandex JA. Reevaluation of total, free and bound protein S and C4b-binding protein levels in plasma anti-coagulated with citrate or hirudin. Blood 1992; 79: 3203-3211.
38. Nelson RM, Long GL. Binding of protein S to C4b-binding protein. J Biol Chem 1992; 267: 8140-8145.
39. Oosting JD et al. Antiphospholipid antibodies directed against a combination of phospholipids with prothrombin, protein C, or protein S: An explanation for their pathogenic mechanism?. Blood 1993; 81: 2618-2625.
40. Wurm H. β2-glycoprotein (apolipoprotein H) interactions with phospholipid vesicles. Int J Biochem 1984; 16: 511-515.
41. Malia RG, Kitchen S, Greaves M, Preston FE. Inhibition of activated protein C and its cofactor protein S by antiphospholipid antibodies. Br J Haematol 1990; 76: 101-107.
42. Ginsberg J et al. Acquired free protein S deficiency is associated with antiphospholipid antibodies and increased thrombin generation in patients with systemic lupus erythematosus. Am J Med 1995; 98: 379-383.